Skip to main content
Anne Goldfeld, MD, Allergy & Immunology, Boston, MA, Brigham and Women's Hospital

AnneEstherGoldfeldMD

Allergy & Immunology Boston, MA

Clinical & Laboratory Immunology

Professor of Medicine, Immune Disease Institute

Are you Dr. Goldfeld?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 51 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Anne Goldfeld, MD is an allergist/immunologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Brigham and Women's Hospital and is a Professor of Medicine at Immune Disease Institute.

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1989 - 1992
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1982 - 1989
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Transitional Year, 1981 - 1982
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1981

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1983 - 2025
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • New Approach May Help Kill Mycobacterium Tuberculosis
    New Approach May Help Kill Mycobacterium TuberculosisNovember 12th, 2019
  • Existing Anti-Parasitic Medication Could Help Fight Against the Ebola Virus
    Existing Anti-Parasitic Medication Could Help Fight Against the Ebola VirusAugust 15th, 2019
  • Could an Already FDA-Approved Drug Be the Key to Treating Ebola?
    Could an Already FDA-Approved Drug Be the Key to Treating Ebola?August 14th, 2019
  • Join now to see all

Grant Support

  • Checkpoints Of TNF Gene RegulationNational Institute Of General Medical Sciences2006–2011
  • HIV-1 Regulation By MTB: Pathogen And Host FactorNational Institute Of Allergy And Infectious Diseases2010
  • T Cell Subsets And Their Function In TB/HIV Paradoxical ReactionsNational Institute Of Allergy And Infectious Diseases2009–2010
  • HIV-1 Regulation By MTB: Pathogen And Host FactorNational Institute Of Allergy And Infectious Diseases2005–2009
  • Genetic Factors And Susceptibility To TuberculosisNational Heart, Lung, And Blood Institute1998–2006
  • Clade-Specific Regulation Of HIV-1 By M TuberculosisNational Institute Of Allergy And Infectious Diseases2004
  • Immunological Activation Of TNF Alpha Gene ExpressionNational Institute Of General Medical Sciences1999–2003
  • Genetic Factors And Susceptibility To TuberculosisNational Heart, Lung, And Blood Institute1997
  • Tnf-Gene Expression In Activated LymphocytesNational Cancer Institute1994–1997
  • TNF Gene Expression In Activated LymphocytesNational Cancer Institute1993
  • Training In Infectious Disease &Molecular BiologyNational Institute Of Allergy And Infectious Diseases1985–1991

Hospital Affiliations